Nordicus Partners (NORD) Cash & Equivalents (2010 - 2026)
Nordicus Partners (NORD) recorded Cash & Equivalents of $5,784 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 31.3% from $8,418 a year earlier and down 72.3% from the prior quarter.
Powered by 
Analysis
Nordicus Partners (NORD) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Nordicus Partners reported Cash & Equivalents of $20,878, up 4.8% from FY2025.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -30.4% (FY2021 to FY2026).
- Across earlier fiscal years, Cash & Equivalents came in at $19,914 in FY2025 (-60.1%), $49,933 in FY2024 (+598.5%), $7,149 in FY2023 (-97.1%) and $245,945 in FY2022 (+92.1%).
- The fiscal Q1 2027 figure is the lowest quarterly Cash & Equivalents since fiscal Q3 2023.
- On a year-over-year basis, Cash & Equivalents rose in four of the last eight quarters, with growth averaging 143.3%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 977.2% in fiscal Q2 2024, against a decline of 99.2% in fiscal Q2 2022 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $20,878 (Q4 2026), $189,297 (Q3 2026) and $242,155 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Nordicus Partners | 67.09 Mn | 66.63 Mn | - | 5,784.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,784.00 |
| Mar 31, 2026 | 20,878.00 |
| Dec 31, 2025 | 189,297.00 |
| Sep 30, 2025 | 242,155.00 |
| Jun 30, 2025 | 8,418.00 |
| Mar 31, 2025 | 19,914.00 |
| Dec 31, 2024 | 28,001.00 |
| Sep 30, 2024 | 46,131.00 |
| Jun 30, 2024 | 26,726.00 |
| Mar 31, 2024 | 49,933.00 |
| Dec 31, 2023 | 38,788.00 |
| Sep 30, 2023 | 10,772.00 |
| Jun 30, 2023 | 32,040.00 |
| Mar 31, 2023 | 7,149.00 |
| Dec 31, 2022 | 5,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 186,000.00 |
| Mar 31, 2022 | 245,945.00 |
| Dec 31, 2021 | 122,000.00 |
| Sep 30, 2021 | 3,000.00 |
API Access
Nordicus Partners Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NORD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NORD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NORD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();